Has Nicholas Fisher received payments from drug or device companies?

Yes. Drug and device makers reported $2,961 in general payments to Nicholas Fisher across 144 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicholas Fisher did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicholas Fisher come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicholas Fisher

Psychiatry · Charleston, SCNPI 1215387006

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.6% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Johnson & Johnson at 26.0% of the total. Reporting peaked in 2023 at $959 and has fallen 57.3% since, to $409 in 2025.

$2,961in general payments, 2019–2025

Across 144 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$769
Otsuka America Pharmaceutical, Inc.$416
Neurocrine Biosciences, Inc.$295
Supernus Pharmaceuticals, Inc.$238
Axsome Therapeutics, Inc.$219
Corium, LLC$197
plus $828 from 13 others

What the payments were for

Food & beverage$2,89098%
Education$712%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	37	$769
Otsuka America Pharmaceutical, Inc.	25	$416
Neurocrine Biosciences, Inc.	11	$295
Supernus Pharmaceuticals, Inc.	9	$238
Axsome Therapeutics, Inc.	13	$219
Corium, LLC	12	$197
Lundbeck LLC	9	$156
Teva Pharmaceuticals USA, Inc.	4	$139
Tris Pharma Inc	7	$127
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$94
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$49
Takeda Pharmaceuticals U.S.A., Inc.	2	$45
Ironshore Pharmaceuticals Inc.	2	$41
Idorsia Pharmaceuticals US Inc	2	$41
Alkermes, Inc.	2	$38
Collegium Pharmaceutical, Inc.	2	$35
Tempus AI, Inc	1	$23
Bausch Health US, LLC	1	$22
Noven Therapeutics, LLC	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPRAVATO$130

How this compares

$2,961 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina →

Other psychiatry in Charleston

Ricardo FermoCharleston$262K
Jacobo MintzerCharleston$132K
Floyd SalleeCharleston$121K
Kathleen BradyCharleston$83K
Jordan SpencerCharleston$62K
James BallengerCharleston$35K
Mark HamnerCharleston$24K
Constance AlexanderCharleston$20K
Mark GeorgeCharleston$17K
Lalithkumar SolaiCharleston$12K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →